Is Tenet Healthcare (THC) Fully Priced As Earnings Near?

Tenet Healthcare (THC) is back in focus as investors brace for this Thursday’s earnings release, with the market watching expected 4.3% year on year revenue growth and a steadier outlook for both core segments.

The share price of Tenet Healthcare has eased in the last week, with a 7 day share price return of down 3.8% and a 1 day move of down 2.6%. However, the year to date share price return of 31.4% and a 1 year total shareholder return of 28.1% still indicate strong longer term momentum, supported by expectations for steady revenue growth from Thursday’s earnings update.

Spot other hospital and healthcare operators that could react sharply around earnings by scanning our curated list of solid balance sheet and fundamentals (24 results).

After a strong run this year and a softer week into earnings, Tenet Healthcare now sits at a trickier crossroads. Does the current valuation still leave enough upside to justify the risks you are taking on?

Most Popular Narrative: 1% Overvalued

The most followed narrative pegs Tenet Healthcare’s fair value at $260, almost level with the last close at $262.05, which leaves very little room for error if the more cautious earnings path plays out.

Tenet Healthcare’s exposure to exchange plan weakness, including a 17% decline in exchange revenues and a one to one move into uninsured volumes in several key states, leaves future hospital revenue and earnings sensitive to further payer mix shifts that may not be fully offset by supplemental Medicaid programs or high acuity service growth.

See why 1 investors see Tenet Healthcare as 1% overvalued.

Result: Fair Value of $260 (OVERVALUED)

Still, a repeat of strong hospital EBITDA margins, or a more supportive shift in higher acuity outpatient volumes at USPI, could challenge the 1% overvaluation story.

Find out about the key risks to this Tenet Healthcare narrative.

Another View: Tenet Healthcare Through The P/E Lens

There is a very different picture when you look at Tenet Healthcare through simple earnings multiples. The stock trades on a P/E of 9.4x, which is far below the US Healthcare industry at 25.6x, the peer average at 20.2x, and even the fair ratio of 19.1x that the market could eventually move toward. That gap points to either a meaningful margin of safety if the bearish earnings path proves too harsh, or a value trap if the profit forecasts turning lower are closer to reality. Which side of that trade do you think the current execution will justify?

To pressure test this earnings based view against the detailed inputs sitting behind it, review how the numbers stack up in our valuation breakdown, then decide how much of that discount really belongs there. See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Plenty of investors are divided on what Tenet Healthcare’s recent run and valuation gap signal for the next chapter. Consider acting while sentiment is still forming and weigh both sides of the story for yourself by checking the 3 key rewards and 3 important warning signs

Looking for more investment ideas beyond Tenet Healthcare?

Do not stop with Tenet Healthcare. Broaden your watchlist now by stress testing different themes, risk levels, and income profiles before the next wave of earnings resets expectations.

• Target potential mispricing by scanning a focused set of quality candidates using the 29 high quality undervalued stocks.
• Lock in steadier income streams by filtering companies built around consistent payouts with the 5 dividend fortresses.
• Dial back portfolio risk by zeroing in on resilient businesses with the 30 resilient stocks with low risk scores.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com